DK Life Science Co., Ltd. (KOSDAQ:303810)

Market Cap	71.00B -48.5%
Revenue (ttm)	117.75B -12.2%
Net Income	4.97B -38.2%
EPS	155.07 -38.8%
Shares Out	31.98M
PE Ratio	14.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,628
Open	2,215.00
Previous Close	2,220.00
Day's Range	2,190.00 - 2,230.00
52-Week Range	2,155.00 - 4,395.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DK Life Science

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2017
• Employees: 100
• Stock Exchange: KOSDAQ
• Ticker Symbol: 303810

Financial Performance

In 2025, DK Life Science's revenue was 130.34 billion, a decrease of -1.12% compared to the previous year's 131.82 billion. Earnings were 8.66 billion, an increase of 285.71%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 14, 2026

Data Sources Report a data error